Dr. Erica Barnell: Stool-Based Detection of Colon Cancer
Talking Biotech with Dr. Kevin Folta
00:00
Genescape C R C Screening Assay
The technology that we developed at genoscape to allow us to use these really important, dynamic signatures tha indicate disease and an leverage that for our diagnostic. So it's a part it's part process. And then subsequently, when this stool sample is received in the laboratory, we go through a series of of steps to isolate the cells, isolate the arna, preserve the arna and then quantify it effectivelyto get a robust signature that we can look at to assess for disease.
Transcript
Play full episode
